Cytotherapy

Article	Citations
Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles	121
International Society for Extracellular Vesicles and International Society for Cell and Gene Therapy statement on extracellular vesicles from mesenchymal stromal cells and other cells: considerations	86
Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial	74
Repeated subarachnoid administrations of allogeneic human umbilical cord mesenchymal stem cells for spinal cord injury: a phase 1/2 pilot study	50
Clinical effects of intrathecal administration of expanded Wharton jelly mesenchymal stromal cells in patients with chronic complete spinal cord injury: a randomized controlled study	49
Generating natural killer cells for adoptive transfer: expanding horizons	45
Mesenchymal stromal cells from dermal and adipose tissues induce macrophage polarization to a pro-repair phenotype and improve skin wound healing	43
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition	43
Adipose tissue and the vascularization of biomaterials: Stem cells, microvascular fragments and nanofat—a review	34
Comparison of regulatory pathways for the approval of advanced therapies in the European Union and the United States	33
Improving mesenchymal stem/stromal cell potency and survival	32
Inducible secretion of IL-21 augments anti-tumor activity of piggyBac-manufactured chimeric antigen receptor T cells	29
Long-term follow-up of CD19 chimeric antigen receptor T-cell therapy for relapsed/refractory acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation	29
Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential	28
Current evidence on mesenchymal stem cell therapy for traumatic spinal cord injury: systematic review and meta-analysis	28
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings	28
The incidence of cytokine release syndrome and neurotoxicity of CD19 chimeric antigen receptor–T cell therapy in the patient with acute lymphoblastic leukemia and lymphoma	27
Advances in generation of three-dimensional skin equivalents: pre-clinical studies to clinical therapies	27
Pre-clinical investigation of mesenchymal stromal cell-derived extracellular vesicles: a systematic review	27
Standardized xeno- and serum-free culture platform enables large-scale expansion of high-quality mesenchymal stem/stromal cells from perinatal and adult tissue sources	26
Irradiated chimeric antigen receptor engineered NK-92MI cells show effective cytotoxicity against CD19+ malignancy in a mouse model	26
Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation	26
Ex vivo-expanded highly pure ABCB5+ mesenchymal stromal cells as Good Manufacturing Practice-compliant autologous advanced therapy medicinal product for clinical use: process validation and first in-h	26
Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies	25
Challenges of manufacturing mesenchymal stromal cell–derived extracellular vesicles in regenerative medicine	25

Autologous bone marrow mesenchymal stromal cell therapy for “no-option” critical limb ischemia is limited by karyotype abnormalities	25
Efficacy and toxicity for CD22/CD19 chimeric antigen receptor T-cell therapy in patients with relapsed/refractory aggressive B-cell lymphoma involving the gastrointestinal tract	24
The effects of intravenous infusion of autologous mesenchymal stromal cells in patients with subacute middle cerebral artery infarct: a phase 2 randomized controlled trial on safety, tolerability and	24
Indirect co-culture of lung carcinoma cells with hyperthermia-treated mesenchymal stem cells influences tumor spheroid growth in a collagen-based 3-dimensional microfluidic model	23
Mechanism for the attenuation of neutrophil and complement hyperactivity by MSC exosomes	23
Transplantation of activated olfactory ensheathing cells by curcumin strengthens regeneration and recovery of function after spinal cord injury in rats	22
Adipose-derived mesenchymal stromal cells reverse high glucose–induced reduction of angiogenesis in human retinal microvascular endothelial cells	21
Human mesenchymal stromal cells small extracellular vesicles attenuate sepsis-induced acute lung injury in a mouse model: the role of oxidative stress and the mitogen-activated protein kinase/nuclear	21
Patient access to and ethical considerations of the application of the European Union hospital exemption rule for advanced therapy medicinal products	20
Umbilical cord blood-derived mesenchymal stromal cells promote myeloid-derived suppressor cell proliferation by secreting HLA-G to reduce acute graft-versus-host disease after hematopoietic stem cell	20
Mesenchymal stem cells: a new front emerges in coronavirus disease 2019 treatment	20
Bortezomib enhances cytotoxicity of ex vivo-expanded gamma delta T cells against acute myeloid leukemia and T-cell acute lymphoblastic leukemia	19
Comparison between centralized and decentralized supply chains of autologous chimeric antigen receptor T-cell therapies: a UK case study based on discrete event simulation	19
An assessment of the hospital exemption landscape across European Member States: regulatory frameworks, use and impact	19
Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing	19
Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries	18
Release kinetic of pro- and anti-inflammatory biomolecules from platelet-rich plasma and functional study on osteoarthritis synovial fibroblasts	18
Adenovirus vector-attributed hepatotoxicity blocks clinical application in gene therapy	17
Understanding the freezing responses of T cells and other subsets of human peripheral blood mononuclear cells using DSMO-free cryoprotectants	17
Advances in automated cell washing and concentration	17
Evaluation of serum-free media formulations in feeder cell–stimulated expansion of natural killer cells	17
The NK-92 cell line—30 years later: its impact on natural killer cell research and treatment of cancer	17
Sirtuin 6 regulates macrophage polarization to alleviate sepsis-induced acute respiratory distress syndrome via dual mechanisms dependent on and independent of autophagy	17
Amniotic fluid-derived extracellular vesicles: characterization and therapeutic efficacy in an experimental model of bronchopulmonary dysplasia	17
Non-invasive monitoring of the kinetic infiltration and therapeutic efficacy of nanoparticle-labeled chimeric antigen receptor T cells in glioblastoma via 7.0-Tesla magnetic resonance imaging	16
Human umbilical cord mesenchymal stromal cells as an adjunct therapy with therapeutic hypothermia in a piglet model of perinatal asphyxia	16
Strategies to enhance immunomodulatory properties and reduce heterogeneity in mesenchymal stromal cells during ex vivo expansion	16
Differentiation of natural killer cells from induced pluripotent stem cells under defined, serum- and feeder-free conditions	16
Umbilical cord-derived mesenchymal stem cells promote myeloid-derived suppressor cell enrichment by secreting CXCL1 to prevent graft-versus-host disease after hematopoietic stem cell transplantation	15
Metabolomics and cytokine profiling of mesenchymal stromal cells identify markers predictive of T-cell suppression	15
Cell culture media notably influence properties of human mesenchymal stroma/stem-like cells from different tissues	15
Porcine acellular dermal matrix accelerates wound healing through miR-124-3p.1 and miR-139-5p	15
Pluripotent stem cell-derived mesenchymal stromal cells improve cardiac function and vascularity after myocardial infarction	14
Secretion of human soluble programmed cell death protein 1 by chimeric antigen receptor-modified T cells enhances anti-tumor efficacy	14
An injectable recombinant human milk fat globule–epidermal growth factor 8–loaded copolymer system for spinal cord injury reduces inflammation through NF-κB and neuronal cell death	14
Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis	14
Comparison of umbilical cord tissue-derived mesenchymal stromal cells isolated from cryopreserved material and extracted by explantation and digestion methods utilizing a split manufacturing model	14
Anti-tumor effects of vascular endothelial growth factor/vascular endothelial growth factor receptor binding domain-modified chimeric antigen receptor T cells	14
Consensus International Council for Commonality in Blood Banking Automation–International Society for Cell & Gene Therapy statement on standard nomenclature abbreviations for the tissue of origin	14
Analysis of ex vivo expanded and activated clinical-grade human NK cells after cryopreservation	14
A novel antibody-cell conjugation method to enhance and characterize cytokine-induced killer cells	14
Safety of allogeneic umbilical cord blood infusions for the treatment of neurological conditions: a systematic review of clinical studies	14
Nanofiltration of growth media supplemented with human platelet lysates for pathogen-safe xeno-free expansion of mesenchymal stromal cells	13
Independent human mesenchymal stromal cell–derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host disease model	13
Safety of autologous bone marrow-derived mesenchymal stem cells in erectile dysfunction: an open-label phase 1 clinical trial	13
Fc-engineered anti-CD33 monoclonal antibody potentiates cytotoxicity of membrane-bound interleukin-21 expanded natural killer cells in acute myeloid leukemia	13
Infrapatellar fat pad-derived mesenchymal stromal cell product for treatment of knee osteoarthritis: a first-in-human study with evaluation of the potency marker	13
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal	13
γδ T cells cultured with artificial antigen-presenting cells and IL-2 show long-term proliferation and enhanced effector functions compared with γδ T cells cultured with only IL-2 after stimulation wi	13
Proteomics profile of mesenchymal stromal cells and extracellular vesicles in normoxic and hypoxic conditions	13

Marrow-Derived Autologous Stromal Cells for the Restoration of Salivary Hypofunction (MARSH): Study protocol for a phase 1 dose-escalation trial of patients with xerostomia after radiation therapy for	12
1,25-dihydroxyvitamin D3 induces stable and reproducible therapeutic tolerogenic dendritic cells with specific epigenetic modifications	12
Phase I Trial of Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stromal Cells in Neonates with Hypoxic-Ischemic Encephalopathy	12
Pseudogene PTENP1 sponges miR-214 to regulate the expression of PTEN to modulate osteoclast differentiation and attenuate osteoporosis	12
Antibodies at work in the time of severe acute respiratory syndrome coronavirus 2	12
Treatment with outgrowth endothelial cells protects cerebral barrier against ischemic injury	12
Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy	12
The application of stem cell therapy and brown adipose tissue transplantation in metabolic disorders	12
Rheumatoid arthritis: From synovium biology to cell-based therapy	12
Effect of mesenchymal stromal cells encapsulated within polyethylene glycol-collagen hydrogels formed in situ on alkali-burned corneas in an ex vivo organ culture model	12
Estimation of manufacturing development costs of cell-based therapies: a feasibility study	12
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myeloma	12
CAR19/22 T cell cocktail therapy for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation	12
Particulate impurities in cell-based medicinal products traced by flow imaging microscopy combined with deep learning for image analysis	11
Registered clinical trials investigating treatment with cell-derived extracellular vesicles: a scoping review	11
Multisite studies for validation and improvement of a highly efficient culture assay for detection of undifferentiated human pluripotent stem cells intermingled in cell therapy products	11
CAR T targets and microenvironmental barriers of osteosarcoma	11
Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?	11
Mesenchymal stromal cells in wound healing applications: role of the secretome, targeted delivery and impact on recessive dystrophic epidermolysis bullosa treatment	11
CD73 activity of mesenchymal stromal cell-derived extracellular vesicle preparations is detergent-resistant and does not correlate with immunomodulatory capabilities	11
A Monte Carlo framework for managing biological variability in manufacture of autologous cell therapy from mesenchymal stromal cells therapies	11
Use of human induced pluripotent stem cells for cartilage regeneration in vitro and within chondral defect models of knee joint cartilage in vivo: a Preferred Reporting Items for Systematic Reviews an	11
Macrophage bioassay standardization to assess the anti-inflammatory activity of mesenchymal stromal cell-derived small extracellular vesicles	11
Conditioned media from mesenchymal stromal cells and periodontal ligament fibroblasts under cyclic stretch stimulation promote bone healing in mouse calvarial defects	11
Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer	10
CD20-specific chimeric antigen receptor-expressing T cells as salvage therapy in rituximab-refractory/relapsed B-cell non-Hodgkin lymphoma	10
Induced pluripotent stem cells derived from the developing striatum as a potential donor source for cell replacement therapy for Huntington disease	10
Progress in the use of mesenchymal stromal cells for osteoarthritis treatment	10
Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?	10
IL-37 overexpression enhances the therapeutic effect of endometrial regenerative cells in concanavalin A-induced hepatitis	10
Identification of protective T-cell antigens for smallpox vaccines	10
Presence of innate lymphoid cells in allogeneic hematopoietic grafts correlates with reduced graft-versus-host disease	10
Bone marrow haploidentical transplant with post-transplantation cyclophosphamide: does graft cell content have an impact on main clinical outcomes?	10
Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche	10
Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells	10
Blockade of transforming growth factor β2 by anti-sense oligonucleotide improves immunotherapeutic potential of IL-2 against melanoma in a humanized mouse model	10
Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies	10
Identification of new cytokine combinations for antigen-specific T-cell therapy products via a high-throughput multi-parameter assay	10
Mesenchymal stem cell secretome protects against alpha-synuclein-induced neurodegeneration in a Caenorhabditis elegans model of Parkinson's disease	10
Combined 4-1BB and ICOS co-stimulation improves anti-tumor efficacy and persistence of dual anti-CD19/CD20 chimeric antigen receptor T cells	10
Imaging flow cytometry challenges the usefulness of classically used extracellular vesicle labeling dyes and qualifies the novel dye Exoria for the labeling of mesenchymal stromal cell–extracellular v	10
Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gen	9
Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering	9
Development of an optimized closed and semi-automatic protocol for Good Manufacturing Practice manufacturing of tumor-infiltrating lymphocytes in a hospital environment	9
HLA-A*02:01-directed chimeric antigen receptor/forkhead box P3-engineered CD4+ T cells adopt a regulatory phenotype and suppress established graft-versus-host disease	9
Identification and characterization of a large source of primary mesenchymal stem cells tightly adhered to bone surfaces of human vertebral body marrow cavities	9
Academic physician specialists’ views toward the unproven stem cell intervention industry: areas of common ground and divergence	9
A novel non-viral delivery method that enables efficient engineering of primary human T cells for ex vivo cell therapy applications	9
CAR-T cell therapy in India requires a paradigm shift in training, education and health care processes	9
miR-21-5p in extracellular vesicles obtained from adipose tissue-derived stromal cells facilitates tubular epithelial cell repair in acute kidney injury	9
Local administration of allogeneic or autologous bone marrow-derived mesenchymal stromal cells enhances bone formation similarly in distraction osteogenesis	9
The safety and efficacy of mesenchymal stem cell therapy in diabetic lower extremity vascular disease: a meta-analysis and systematic review	9
Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label c	9
Derivation of clinical-grade mesenchymal stromal cells from umbilical cord under chemically defined culture condition – platform for future clinical application	9
Dental pulp stem cell-derived extracellular matrix: autologous tool boosting bone regeneration	8
Mesenchymal stem/stromal cells stably transduced with an inhibitor of CC chemokine ligand 2 ameliorate bronchopulmonary dysplasia and pulmonary hypertension	8
Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective	8
CCR7 expression in CD19 chimeric antigen receptor-engineered natural killer cells improves migration toward CCL19-expressing lymphoma cells and increases tumor control in mice with human lymphoma	8
Stem cell therapy in coronavirus disease 2019: current evidence and future potential	8
Towards sustainability and affordability of expensive cell and gene therapies? Applying a cost-based pricing model to estimate prices for Libmeldy and Zolgensma	8
A PHASE I CLINICAL TRIAL ON INTRAVENOUS ADMINISTRATION OF IMMATURE HUMAN DENTAL PULP STEM CELLS (NESTACELL HDTM) TO HUNTINGTON'S DISEASE PATIENTS	8
Qualification of a multidonor mixed lymphocyte reaction assay for the functional characterization of immunomodulatory extracellular vesicles	8
Characterizing human mesenchymal stromal cells’ immune-modulatory potency using targeted lipidomic profiling of sphingolipids	8
Dimethyl sulfoxide-free cryopreservation solutions for hematopoietic stem cell grafts	8
Human umbilical cord tissue-derived mesenchymal stromal cells as adjuvant therapy for myocardial infarction: a review of current evidence focusing on pre-clinical large animal models and early human t	8
Extracorporeal photopheresis as first-line strategy in the treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation: A single-center experience	8
Validation of a flow cytometry-based method to quantify viable lymphocyte subtypes in fresh and cryopreserved hematopoietic cellular products	8
Artificial feeder cells expressing ligands for killer cell immunoglobulin-like receptors and CD94/NKG2A for expansion of functional primary natural killer cells with tolerance to self	8
Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials	8
Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer	8
Transcriptional dynamics of induced pluripotent stem cell differentiation into β cells reveals full endodermal commitment and homology with human islets	8
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome	8
Effect of intramuscular baculovirus encoding mutant hypoxia-inducible factor 1-alpha on neovasculogenesis and ischemic muscle protection in rabbits with peripheral arterial disease	7
Cartilage regeneration with human dental pulp stem cells - a systematic review	7
Metformin pre-treatment of stem cells from human exfoliated deciduous teeth promotes migration and angiogenesis of human umbilical vein endothelial cells for tissue engineering	7
Accelerating the development of innovative cellular therapy products for the treatment of cancer	7
Infusion reactions in natural killer cell immunotherapy: a retrospective review	7
γc cytokine-aided crosstalk between dendritic cells and natural killer cells together with doxorubicin induces a healer response in experimental lymphoma by downregulating FOXP3 and programmed cell de	7
A comprehensive report of long-term stability data for a range ATMPs: A need to develop guidelines for safe and harmonized stability studies	7
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus diseas	7

Mapping human serum–induced gene networks as a basis for the creation of biomimetic periosteum for bone repair	7
Expansion and CD2/CD3/CD28 stimulation enhance Th2 cytokine secretion of human invariant NKT cells with retained anti-tumor cytotoxicity	7
A novel predictive algorithm to personalize autologous T-cell harvest for chimeric antigen receptor T-cell manufacture	7
Cryopreserved bone marrow aspirate concentrate as a cell source for the colony-forming unit fibroblast assay	7
In vitro induction of neoantigen-specific T cells in myelodysplastic syndrome, a disease with low mutational burden	7
Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor–natural killer cells	7
Response to extracorporeal photopheresis therapy of patients with steroid-refractory/-resistant GvHD is associated with up-regulation of Th22 cells and Tfh cells	7
Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies	7
Identification of marker genes to monitor residual iPSCs in iPSC-derived products	7
Multiply restimulated human thymic regulatory T cells express distinct signature regulatory T-cell transcription factors without evidence of exhaustion	6
Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much?	6
Small extracellular vesicles from mesenchymal stromal cells: the next therapeutic paradigm for musculoskeletal disorders	6
Minor salivary gland mesenchymal stromal cells derived from patients with Sjӧgren's syndrome deploy intact immune plasticity	6
High-throughput assessment of mutations generated by genome editing in induced pluripotent stem cells by high-resolution melting analysis	6
MAGT1 messenger RNA-corrected autologous T and natural killer cells for potential cell therapy in X-linked immunodeficiency with magnesium defect, Epstein-Barr virus infection and neoplasia disease	6
Transient warming affects potency of cryopreserved cord blood units	6
Adoptive transfer of neoantigen-specific T-cell therapy is feasible in older patients with higher-risk myelodysplastic syndrome	6
Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the Eu	6
A serum-free protocol for the ex vivo expansion of Cytokine-Induced Killer cells using gas-permeable static culture flasks	6
Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufac	6
Transient blockade of TBK1/IKKε allows efficient transduction of primary human natural killer cells with vesicular stomatitis virus G-pseudotyped lentiviral vectors	6
A roadmap from research to clinical testing of mesenchymal stromal cell exosomes in the treatment of psoriasis	6
Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19+ hematologic indications	6
Impact of storage conditions and duration on function of native and cargo-loaded mesenchymal stromal cell extracellular vesicles	6
Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains	6
Evaluation of a clinical-grade, cryopreserved, ex vivo-expanded stem cell product from cryopreserved primary umbilical cord blood demonstrates multilineage hematopoietic engraftment in mouse xenograft	6
Engineering mesenchymal stem cell paracrine activity with 3D culture	6
The capacity of CD4+ Vγ9Vδ2 T cells to kill cancer cells correlates with co-expression of CD56	6
Prophylactic tocilizumab before CD3/4-1bb anti-CD19 car-T cell infusion decreases incidence of severe crs without increased risk of neurotoxicity	6
Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies	6
Live cell imaging of highly activated natural killer cells against human hepatocellular carcinoma in vivo	5
Phospholipids in small extracellular vesicles: emerging regulators of neurodegenerative diseases and cancer	5
Development of an induced pluripotent stem cell–specific microRNA assay for detection of residual undifferentiated cells in natural killer cell therapy products	5
Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019	5
Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor era	5
Development of a B-cell maturation antigen-specific T-cell antigen coupler receptor for multiple myeloma	5
Stem cells from human exfoliated deciduous teeth affect mitochondria and reverse cognitive decline in a senescence-accelerated mouse prone 8 model	5
Directly test individual T cell function with fewer cells on the berkeley lights lightning™ platform	5
Characterization of heterogeneous primary human cartilage-derived cell population using non-invasive live-cell phase-contrast time-lapse imaging	5
Allogeneic cord blood regulatory T cells can resolve lung inflammation	5
Mobilization kinetics of CD34+ hematopoietic stem cells stimulated by G-CSF and cyclophosphamide in patients with multiple sclerosis who receive an autotransplant	5
Role of mesenchymal stromal cells derivatives in diabetic foot ulcers: a controlled randomized phase 1/2 clinical trial	5
Endoscopic atomization of mesenchymal stromal cells: in vitro study for local cell therapy of the lungs	5
The new legal framework for minimally manipulated cells expands the possibilities for cell therapy in Russia	5
Technological advances in study of lung regenerative medicine:perspective from the 2019 Vermont lung stem cell conference	5
High yield and scalable EV production from suspension cells triggered by turbulence in a bioreactor	5
Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell–derived IL-6 is reversed predominantly by IL-6 blockade	5
Magnetic 3D Bioprinting for Personalized Medicine.	5
Off-the-shelf ipsc derived car-nk immunotherapy for solid tumors	5
Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition	5
Recent advances in cellular therapy for malignant lymphoma	5
A report on the International Society for Cell & Gene Therapy 2022 Scientific Signature Series, “Therapeutic advances with native and engineered human extracellular vesicles”	5
Systematic review and meta-analysis of the association between bridging therapy and outcomes of chimeric antigen receptor T cell therapy in patients with large B cell lymphoma	5
ISCT survey on hospital practices to support externally manufactured investigational cell-gene therapy products	5
Stem cell-derived exosomes in bone healing: focusing on their role in angiogenesis	5
Optimization of therapeutic T cell expansion in G-Rex device and applicability to large-scale production for clinical use	5
Soluble factors differ in platelets derived from separate niches: a pilot study comparing the secretome of peripheral blood and bone marrow platelets	5
CD40L-expressing CD4+ T cells prime adipose-derived stromal cells to produce inflammatory chemokines	5
Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapy	5
Characterization and response to inflammatory stimulation of human endometrial-derived mesenchymal stem/stromal cells	5
Perspectives on establishing a public cord blood inventory in South Africa	5
An off the shelf, GMP compliant,fully closed and semi-automated large-scale production system for allogeneic NK cells	4
The systemic administration of neural stem cells expressing an inducible and soluble form of growth arrest specific 1 inhibits mammary gland tumor growth and the formation of metastases	4
Human CAR-T Cells engineered using the Solupore Ex Vivo Cell Engineering Platform are highly cytotoxic and specific against CD19+ cells in vitro	4
A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan Blood and Tissue Bank experience	4
Evaluation of human adipose-derived mesenchymal stromal cell Toll-like receptor priming and effects on interaction with prostate cancer cells	4
Rapid single-cell identification of Epstein–Barr virus-specific T-cell receptors for cellular therapy	4
CRISPR-Cas9 base editors and their current role in human therapeutics	4
Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019	4
Reversion of early- and late-stage β-cell dedifferentiation by human umbilical cord-derived mesenchymal stem cells in type 2 diabetic mice	4
Exosomes derived from adipose mesenchymal stem cells: a potential non-invasive intranasal treatment for autism	4
Removal of minute virus of mice-mock virus particles by nanofiltration of culture growth medium supplemented with 10% human platelet lysate	4
Manufacturing and validation of Good Manufacturing Practice–compliant regulatory dendritic cells for infusion into organ transplant recipients	4
Engineering of regulatory T cells by means of mRNA electroporation in a GMP-compliant manner	4
Splenic macrophage phagocytosis of intravenously infused mesenchymal stromal cells attenuates tumor localization	4
Longitudinal two-dimensional gas chromatography mass spectrometry as a non-destructive at-line monitoring tool during cell manufacturing identifies volatile features correlative to cell product qualit	4
Improving cell viability using counterflow centrifugal elutriation	4
Promoting the ethical use of safe and effective cell-based products: the Andalusian plan on regenerative medicine	4
Reference gene selection for clinical chimeric antigen receptor T-cell product vector copy number assays	4
Immune Reprogramming in Human Subjects after Extracorporeal Mesenchymal Stromal Cell Therapy	4
Effect of mesenchymal stromal cell transplantation on long-term survival in amyotrophic lateral sclerosis	4
An industry survey of implementation strategies for clinical supply chain management of cell and gene therapies	4
Editing human hematopoietic stem cells: advances and challenges	4
A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin	4
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone	4
Crowdfunding, stem cell interventions and autism spectrum disorder: comparing campaigns related to an international “stem cell clinic” and US academic medical center	4
Safety of sibling cord blood cell infusion for children with cerebral palsy	4
Application of decellularized human reticular allograft dermal matrix promotes rapid re-epithelialization in a diabetic murine excisional wound model	4
Targeting of low ALK antigen density neuroblastoma using AND logic-gate engineered CAR-T cells	4
CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders	4
Combinatorial antigen targeting strategies for acute leukemia: application in myeloid malignancy	4
Effect of alemtuzumab-based T-cell depletion on graft compositional change in vitro and immune reconstitution early after allogeneic stem cell transplantation	4
Reduced dimethyl sulfoxide concentrations successfully cryopreserve human hematopoietic stem cells with multi-lineage long-term engraftment ability in mice	4
Predictive analytics and cord blood banking: toward utilization-based unit selection	4
Consequences of adjusting cell density and feed frequency on serum-free expansion of thymic regulatory T cells	4